Showing 304 results
January 2014
-
Media ReleaseGermany approves Sandoz’s Airflusal® Forspiro®Holzkirchen, Germany, January 13, 2014 - Sandoz announced today it has received German marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.…
-
Media ReleaseNovartis publishes Corporate Responsibility OverviewJanuar 08, 2014 - Novartis recently published a comprehensive overview of its Corporate Responsibility strategy and programs. Learn more (PDF 743 KB)
-
Media ReleaseSandoz biosimilar filgrastim recommended for approval by FDA Oncologic Drugs Advisory CommitteeOncologic Drugs Advisory Committee (ODAC) votes in favor of recommending biosimilar filgrastim for approval in the US Biosimilar filgrastim recommended to be approved for use in all requested…